Approach to Premenstrual Dysphoria for the Mental Health Practitioner

Psychiatric Clinics of North America

Volumn 33, Issue 2, 2010, Pages 257-272

  Vigod, Simone N ^a   Frey, Benicio N ^b,c   Soares, Claudio N ^b,c   Steiner, Meir ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Women's Health Concerns Clinic   (Canada)

Author keywords

Dysphoria; Mental Health; Mood disorder; PMDD; PMS

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; ANDROGEN; CALCIUM; CITALOPRAM; CLOMIPRAMINE; DANAZOL; DROSPIRENONE; DULOXETINE; ETHINYLESTRADIOL; FLUOXETINE; FLUVOXAMINE; GONADORELIN AGONIST; LEUPRORELIN; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PLACEBO; PYRIDOXINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VITEX AGNUS CASTUS EXTRACT;

ACNE; ACUPUNCTURE; ALTERNATIVE MEDICINE; BIPOLAR DISORDER; CARBOHYDRATE INTAKE; CHINESE MEDICINE; CHIROPRACTIC; CLINICAL TRIAL; COGNITIVE THERAPY; DEEP VEIN THROMBOSIS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG SAFETY; FAMILY HISTORY; GUIDED IMAGERY; HEREDITY; HUMAN; LIFESTYLE; LOW DRUG DOSE; MASSAGE; MENSTRUAL CYCLE; MENTAL HEALTH; MENTAL INSTABILITY; MINOR AFFECTIVE DISORDER; MOOD DISORDER; OSTEOPOROSIS; PATHOPHYSIOLOGY; PATIENT EDUCATION; PERIPHERAL NEUROPATHY; PHOTOSTIMULATION; PHOTOTHERAPY; PHYSICAL DISEASE; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PREVALENCE; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOPHYSIOLOGY; PSYCHOTHERAPIST; PSYCHOTHERAPY; REFLEXOLOGY; RELAXATION TRAINING; REVIEW; SIDE EFFECT; SOCIAL PSYCHOLOGY; VIRILIZATION; WEIGHT GAIN; YOGA;

ADULT; BIOLOGICAL PSYCHIATRY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; MENTAL HEALTH SERVICES; MOOD DISORDERS; PREMENSTRUAL SYNDROME;

EID: 77951454973     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2010.01.008     Document Type: Review

References (107)

1. Delaney J., Lupton M.J., Toth E. The curse: a cultural history of menstruation 1976, E.P. Dutton, New York.
2. Chrisler J.C., Johnston-Robledo I. Raging hormones? Feminist perspectives on premenstrual syndrome and postpartum depression. Rethinking mental health and disorder: feminist perspectives 2002, 174-197. Guilford Press, New York. M. Ballou, L.S. Brown (Eds.).
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, Text revision (DSM-IV-TR), American Psychiatric Association, Washington, DC, p. 771-4. Fourth edition.
4. American College of Obstetricians and Gynecologists. Premenstrual syndrome. Patient Education Pamphlet, by the American College of Obstetricians and Gynecologists; 2003. Available at: Accessed February 16, 2010. http://www.acog.org/publications/patient_education/bp057.cfm.
5. Wittchen H.U., Becker E., Lieb R., et al. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 2002, 32:119-132.
6. Steiner M., Macdougall M., Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health 2003, 6(3):203-209.
7. Takeda T., Tasaka K., Sakata M., et al. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Arch Womens Ment Health 2006, 9(4):209-212.
8. Cohen L.S., Soares C.N., Otto M.W., et al. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. J Affect Disord 2002, 70:125-132.
9. Rivera-Tovar A.D., Frank E. Late luteal phase dysphoric disorder in young women. Am J Psychiatry 1990, 147:1634-1636.
10. Banerjee N., Roy K.K., Takkar D. Premenstrual dysphoric disorder-a study from India. Int J Fertil Womens Med 2000, 45:342-344.
11. Rojnic Kuzman M., Hotujac L. Premenstrual dysphoric disorder-a neglected diagnosis? Preliminary study on a sample of Croatian students. Coll Antropol 2007, 31(1):131-137.
12. Sveindottir H., Backstrom T. Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Acta Obstet Gynecol Scand 2000, 79(5):405-413.
13. Gehlert S., Song I.H., Chang C.H., et al. The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women. Psychol Med 2009, 39(1):129-136.
14. Freeman E.W., Rickels K., Schweizer E., et al. Relationships between age and symptom severity among women seeking medical treatment for premenstrual symptoms. Psychol Med 1995, 25:309-315.
15. Marvan M.L., Diaz-Erosa M., Montesinos A. Premenstrual symptoms in Mexican women with different educational levels. J Psychol 1998, 132:517-526.
16. Soares C.N., Cohen L.S., Otto M.W., et al. Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard Study of Moods and Cycles. J Womens Health Gend Based Med 2001, 10:873-878.
17. Beck L.E., Gevirtz R., Mortola J.F. The predictive role of psychosocial stress on symptom severity in premenstrual syndrome. Psychosom Med 1990, 52:536-543.
18. Warner P., Bancroft J. Factors related to self-reporting of the pre-menstrual syndrome. Br J Psychiatry 1990, 157:249-260.
19. Fontana A.M., Palfai T.G. Psychosocial factors in premenstrual dysphoria: stressors, appraisal, and coping processes. J Psychosom Res 1994, 38:557-567.
20. Paddison P.L., Gise L.H., Lebovits A., et al. Sexual abuse and premenstrual syndrome: comparison between a lower and higher socioeconomic group. Psychosomatics 1990, 3:265-272.
21. Friedman R.C., Hurt S.W., Clarkin J., et al. Sexual histories and premenstrual affective syndrome in psychiatric inpatients. Am J Psychiatry 1982, 139:1484-1486.
22. MacMillan H.L., Fleming J.E., Streiner D.L., et al. Childhood abuse and lifetime psychopathology in a community sample. Am J Psychiatry 2001, 158:1878-1883.
23. Woods N.F., Most A., Longenecker G.D. Major life events, daily stressors, and perimenstrual symptoms. Nurse Res 1985, 34:263-267.
24. Kendler K.S., Karkowski L.M., Corey L.A., et al. Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiatry 1998, 155:1234-1240.
25. Treloar S.A., Heath A.C., Martin N.G. Genetic and environmental influences on premenstrual symptoms in an Australian twin sample. Psychol Med 2002, 32(1):25-38.
26. Payne J.L., Palmer J.T., Joffe H. A reproductive subtype of depression: conceptualizing models and moving toward etiology. Harv Rev Psychiatry 2009, 17(2):72-86.
27. Steiner M., Brown E., Trzepacz P., et al. Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder. Arch Womens Ment Health 2003, 6:71-77.
28. Chawla A., Swindle R., Long S., et al. Premenstrual dysphoric disorder: is there an economic burden of illness?. Med Care 2002, 40:1101-1112.
29. Yang M., Wallenstein G., Hagan M., et al. Burden of premenstrual dysphoric disorder on health-related quality of life. J Womens Health (Larchmt) 2008, 17(1):113-121.
30. Rubinow D.R., Roy-Byrne P., Hoban M.C., et al. Prospective assessment of menstrually related mood disorders. Am J Psychiatry 1984, 141:684-686.
31. Meaden P.M., Hartlage S.A., Cook-Karr J. Timing and severity of symptoms associated with the menstrual cycle in a community-based sample in the Midwestern United States. Psychiatry Res 2005, 134(1):27-36.
32. Lane T., Francis A. Premenstrual symptomatology, locus of control, anxiety and depression in women with normal menstrual cycles. Arch Womens Ment Health 2003, 6(2):127-138.
33. Pearlstein T., Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci 2008, 33(4):291-301.
34. Smith M.J., Schmidt P.J., Rubinow D.R. Operationalizing DSM-IV criteria for PMDD: selecting symptomatic and asymptomatic cycles for research. J Psychiatr Res 2003, 37:75-83.
35. Steiner M., Peer M., Soares C.N. Comorbidity and premenstrual syndrome: recognition and treatment approaches. Gynaecology Forum 2006, 11:13-16.
36. Steiner M., Born L. Psychiatric aspects of the menstrual cycle. Women's mental health: a comprehensive textbook 2002, 48-69. Guilford Press, New York. S.G. Kornstein, A.H. Clayton (Eds.).
37. Hartlage S.A., Brandenburg D.L., Kravitz H.M. Premenstrual exacerbation of depressive disorders in a community-based sample in the United States. Psychosom Med 2004, 66(5):698-706.
38. Kornstein S.G., Harvey A.T., Rush A.J., et al. Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression. Psychol Med 2005, 35(5):683-692.
39. Kim D.R., Gyulai L., Freeman E.W., et al. Premenstrual dysphoric disorder and psychiatric co-morbidity. Arch Womens Ment Health 2004, 7(1):37-47.
40. Critchlow D.G., Bond A.J., Wingrove J. Mood disorder history and personality assessment in premenstrual dysphoric disorder. J Clin Psychiatry 2001, 62(9):688-693.
41. Johnson T.M. Premenstrual syndrome as a Western culture-specific disorder. Cult Med Psychiatry 1987, 11:337-356.
42. Anson O. Exploring the bio-psycho-social approach to premenstrual experiences. Soc Sci Med 1999, 49:67-80.
43. Marvan M.L., Escobedo C. Premenstrual symptomatology: role of prior knowledge about premenstrual syndrome. Psychosom Med 1999, 61:163-167.
44. Ruble D.N. Premenstrual symptoms: a reinterpretation. Science 1977, 197:291-292.
45. Schmidt P.J., Nieman L.K., Danaceau M.A., et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998, 338:209-216.
46. Eriksson O., Backstrom T., Stridsberg M., et al. Differential response to estrogen challenge test in women with and without premenstrual dysphoria. Psychoneuroendocrinology 2006, 31(4):415-427.
47. Freeman E.W., Frye C.A., Rickels K., et al. Allopregnanolone levels and symptom improvement in severe premenstrual syndrome. J Clin Psychopharmacol 2002, 22:516-520.
48. Nyberg S., Backstrom T., Zingmark E., et al. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome. Gynecol Endocrinol 2007, 23(5):257-266.
49. Andreen L., Nyberg S., Turkmen S., et al. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology 2009, 34(8):1121-1132.
50. Epperson C.N., Haga K., Mason G.F., et al. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 2002, 59:851-858.
51. Sundstrom I., Andersson A., Nyberg S., et al. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 1998, 67(2):126-138.
52. Le Melledo J.M., Van Driel M., Coupland N.J., et al. Response to flumazenil in women with premenstrual dysphoric disorder. Am J Psychiatry 2000, 157:821-823.
53. Sundstrom I., Ashbrook D., Backstrom T. Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study. Psychoneuroendocrinology 1997, 22:25-38.
54. Sundstrom I., Nyberg S., Backstrom T. Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology 1997, 17:370-381.
55. Sundstrom I., Backstrom T. Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial. Psychoneuroendocrinology 1998, 23(1):73-88.
56. Eriksson E., Sundblad C., Landen M., et al. Behavioural effects of androgens in women. Mood disorders in women 2000, 233-246. Martin Dunitz, London. M. Steiner, K.A. Yonkers, E. Eriksson (Eds.).
57. Steiner M., Dunn E.J., MacDougall M., et al. Serotonin transporter gene polymorphism, free testosterone, and symptoms associated with premenstrual dysphoric disorder. Biol Psychiatry 2002, 51:91S.
58. Bloch M., Schmidt P.J., Su T.P., et al. Pituitary-adrenal hormones and testosterone across the menstrual cycle in women with premenstrual syndrome and controls. Biol Psychiatry 1998, 43:897-903.
59. Steiner M., Pearlstein T. Premenstrual dysphoria and the serotonin system: pathophysiology and treatment. J Clin Psychiatry 2000, 61(Suppl 12):17-21.
60. Rapkin A.J., Edelmuth E., Chang L.C., et al. Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol 1987, 70:533-537.
61. Taylor D.L., Mathew R.J., Ho B.T., et al. Serotonin levels and platelet uptake during premenstrual tension. Neuropsychobiology 1984, 12:16-18.
62. Melke J., Westberg L., Landen M., et al. Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria. Psychoneuroendocrinology 2003, 28(3):446-458.
63. Jovanovic H., Cerin A., Karlsson P., et al. A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria. Psychiatry Res 2006, 148(2-3):185-193.
64. Bancroft J., Cook A., Davidson D., et al. Blunting of neuroendocrine responses to infusion of l-tryptophan in women with perimenstrual mood change. Psychol Med 1991, 21:305-312.
65. Yatham L.N. Is 5HT1α receptor subsensitivity a trait marker for late luteal phase dysphoric disorder? A pilot study. Can J Psychiatry 1993, 38:662-664.
66. FitzGerald M., Malone K.M., Li S., et al. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. Am J Psychiatry 1997, 154:556-558.
67. Steiner M., Yatham L.N., Coote M., et al. Serotonergic dysfunction in women with pure premenstrual dysphoric disorder: is the fenfluramine challenge test still relevant?. Psychiatry Res 1999, 87:107-115.
68. Rasgon N., Serra M., Biggio G., et al. Neuroactive steroid-serotonergic interaction: responses to an intravenous l-tryptophan challenge in women with premenstrual syndrome. Eur J Endocrinol 2001, 145:25-33.
69. Mitwally M.F., Kahn L.S., Halbreich U. Pharmacotherapy of premenstrual syndromes and premenstrual dysphoric disorder: current practices. Expert Opin Pharmacother 2002, 3:1577-1590.
70. Praschak-Rieder N., Willeit M., Winkler D., et al. Role of family history and 5-HTTLPR polymorphism in female seasonal affective disorder patients with and without premenstrual dysphoric disorder. Eur Neuropsychopharmacol 2002, 12(2):129-134.
71. Huo L., Straub R.E., Roca C., et al. Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biol Psychiatry 2007, 62(8):925-933.
72. Heim C., Newport D.J., Heit S., et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 2000, 284:592-597.
73. Kendler K.S., Gardner C.O., Prescott C.A. Toward a comprehensive developmental model for major depression in women. Am J Psychiatry 2002, 159:1133-1145.
74. Ornitz A.W., Brown M.A. Family coping and premenstrual symptomatology. J Obstet Gynecol Neonatal Nurs 1993, 22:49-55.
75. Matsumoto T., Ushiroyama T., Kimura T., et al. Altered autonomic nervous system activity as a potential etiological factor of premenstrual syndrome and premenstrual dysphoric disorder. Biopsychosoc Med 2007, 1:24.
76. Bunevicius R., Hinderliter A.L., Light K.C., et al. Histories of sexual abuse are associated with differential effects of clonidine on autonomic function in women with premenstrual dysphoric disorder. Biol Psychol 2005, 69(3):281-296.
77. Jarvis C.I., Lynch A.M., Morin A.K. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder. Ann Pharmacother 2008, 42(7):967-978.
78. Frackiewicz E.J., Shiovitz T.M. Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder. J Am Pharm Assoc 2001, 41:437-447.
79. Baker F.C., Kahan T.L., Trinder J., et al. Sleep quality and the sleep electroencephalogram in women with severe premenstrual syndrome. Sleep 2007, 30(10):1283-1291.
80. Thys-Jacobs S., Starkey P., Bernstein D., et al. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol 1998, 179:444-452.
81. Williams A.L., Cotter A., Sabina A., et al. The role for vitamin B-6 as treatment for depression: a systematic review. Fam Pract 2005, 22(5):532-537.
82. Kashanian M., Mazinani R., Jalalmanesh S. Pyridoxine (vitamin B6) therapy for premenstrual syndrome. Int J Gynaecol Obstet 2007, 96(1):43-44.
83. Wyatt K.M., Dimmock P.W., Jones P.W., et al. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 1999, 318:1375-1381.
84. Sayegh R., Schiff I., Wurtman J., et al. The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome. Obstet Gynecol 1995, 86:520-528.
85. Freeman E.W., Stout A.L., Endicott J., et al. Treatment of premenstrual syndrome with a carbohydrate-rich beverage. Int J Gynaecol Obstet 2002, 77(3):253-254.
86. Khine K., Rosenstein D.L., Elin R.J., et al. Magnesium (Mg) retention and mood effects after intravenous Mg infusion in premenstrual dysphoric disorder. Biol Psychiatry 2006, 59(4):327-333.
87. Bendich A. The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms. J Am Coll Nutr 2000, 19:3-12.
88. Morse G. Positively reframing perceptions of the menstrual cycle among women with premenstrual syndrome. J Obstet Gynecol Neonatal Nurs 1999, 28:165-174.
89. Walton J., Youngkin E. The effect of a support group on self-esteem of women with premenstrual syndrome. J Obstet Gynecol Neonatal Nurs 1987, 16:174-178.
90. Seideman R.Y. Effects of a premenstrual syndrome education program on premenstrual symptomatology. Health Care Women Int 1990, 11:491-501.
91. Taylor D. Effectiveness of professional-peer group treatment: symptom management for women with PMS. Res Nurs Health 1999, 22:496-511.
92. Goodale I.L., Domar A.D., Benson H. Alleviation of premenstrual syndrome symptoms with the relaxation response. Obstet Gynecol 1990, 75:649-655.
93. Morse C.A., Dennerstein L., Farrell E., et al. A comparison of hormone therapy, coping skills training, and relaxation for the relief of premenstrual syndrome. J Behav Med 1991, 14:469-489.
94. Lustyk M.K., Gerrish W.G., Shaver S., et al. Cognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health 2009, 12(2):85-96.
95. Steiner M., Pearlstein T., Cohen L.S., et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt) 2006, 15(1):57-69.
96. Brown J., O'Brien P.M., Marjoribanks J., et al. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2009, (2). CD001396.
97. Freeman E.W., Rickels K., Yonkers K.A., et al. Venlafaxine in the treatment of premenstrual dysphoric disorder. Obstet Gynecol 2001, 98(5):737-744.
98. Ramos M.G., Hara C., Rocha F.L. Duloxetine treatment for women with premenstrual dysphoric disorder: a single-blind trial. Int J Neuropsychopharmacol 2009, 12(8):1081-1088.
99. Freeman E.W., Rickels K., Sammel M.D., et al. Time to relapse after short- or long-term treatment of severe premenstrual syndrome with sertraline. Arch Gen Psychiatry 2009, 66(5):537-544.
100. Lopez L.M., Kaptein A.A., Helmerhorst F.M. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev 2009, (2). CD006586.
101. Muse K.N., Cetel N.S., Futterman L.A., et al. The premenstrual syndrome: effects of " medical ovariectomy" N Engl J Med 1984, 311:1345-1349.
102. Freeman E.W., Sondheimer S.J., Rickels K. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Psychopharmacol Bull 1997, 33:303-309.
103. O'Brien P.M.S., Abukhalil I. Randomised controlled trial of the management of premenstrual mastalgia using luteal phase only Danazol. Am J Obstet Gynecol 1999, 180:18-23.
104. Cronje W.H., Vashisht A., Studd J.W.W. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Humanit Rep 2004, 19(9):2152-2155.
105. Agha-Hosseini M., Kashani L., Aleyaseen A., et al. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG 2008, 115(4):515-519.
106. Jang H.S., Lee M.S. Effects of qi therapy (external qigong) on premenstrual syndrome: a randomized placebo-controlled study. J Altern Complement Med 2004, 10(3):456-462.
107. Krasnik C., Montori V.M., Guyatt G.H., et al. Medically Unexplained Syndromes Study Group. The effect of bright light therapy on depression associated with premenstrual dysphoric disorder. Am J Obstet Gynecol 2005, 193(3 Pt 1):658-661.